Search research articles
Contact Us
Filters
Showing results (431-440 of 575) with videos related to
Page
of 58
Sort By:
Journal of Comparative Effectiveness Research
|
January 22, 2020
Crizotinib versus chemotherapy: a real-world cost-effectiveness study in China
Meijuan Huang, Yuke Tian, Mingmin He, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 3, 2025
Low-dose Radiation Therapy Concurrent With Atezolizumab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: 3-Year Follow-up of a Multicenter, Single-arm, Phase 2 Trial (MATCH)
Lin Zhou, Jianguo Sun, Conghua Xie, et al.
Environmental Toxicology
|
March 14, 2022
Edible folic acid and medicinal folinic acid produce cardioprotective effects in late-stage triple-transgenic Alzheimer's disease model mice by suppressing cardiac hypertrophy and fibrosis
Chih-Yang Huang, Yi-Chen Su, Cheng-You Lu, et al.
Environmental Toxicology
|
January 15, 2021
Cardioprotective potential of amygdalin against angiotensin II induced cardiac hypertrophy, oxidative stress and inflammatory responses through modulation of Nrf2 and NF-κB activation
Yen-Lun Kung, Cheng-You Lu, Khan Fareen Badrealam, et al.
Annals of Surgical Oncology
|
October 26, 2018
A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study
Xin Tang, Xiaojuan Zhou, Yanying Li, et al.
Translational Lung Cancer Research
|
November 14, 2025
Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory study
Yijia Du, Yanying Li, Min Yu, et al.
Journal of the American Chemical Society
|
July 7, 2026
Interfacial Nucleation Pathways Governing Polymorph Selection Revealed by Synchrotron-Based <i>In Situ</i> GIWAXS and Molecular Simulations
Yu Liu, Xu Zhang, Xingfan Zhang, et al.
British Journal of Cancer
|
February 14, 2018
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)
Baohui Han, Kai Li, Yizhuo Zhao, et al.
BMC Cancer
|
February 7, 2015
Concurrent paclitaxel-based chemo-radiotherapy for post-surgical microscopic residual tumor at the bronchial margin (R1 resection) in non-small-cell lung cancer
Meixiang Zhou, Tao Li, Yongmei Liu, et al.
JTO Clinical and Research Reports
|
November 17, 2025
AdvanTIG-204: A Phase 2, Randomized, Open-Label Study of Ociperlimab Plus Tislelizumab and Concurrent Chemoradiotherapy Versus Tislelizumab and Concurrent Chemotherapy Versus Concurrent Chemoradiotherapy in First-Line Limited-Stage SCLC
Youling Gong, Qingsong Pang, Rong Yu, et al.
Page
of 58
Search research articles
Search
Showing results (431-440 of 575) with videos related to
Sort By:
Page
of 58
Journal of Comparative Effectiveness Research
|
January 22, 2020
Crizotinib versus chemotherapy: a real-world cost-effectiveness study in China
Meijuan Huang, Yuke Tian, Mingmin He, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 3, 2025
Low-dose Radiation Therapy Concurrent With Atezolizumab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: 3-Year Follow-up of a Multicenter, Single-arm, Phase 2 Trial (MATCH)
Lin Zhou, Jianguo Sun, Conghua Xie, et al.
Environmental Toxicology
|
March 14, 2022
Edible folic acid and medicinal folinic acid produce cardioprotective effects in late-stage triple-transgenic Alzheimer's disease model mice by suppressing cardiac hypertrophy and fibrosis
Chih-Yang Huang, Yi-Chen Su, Cheng-You Lu, et al.
Environmental Toxicology
|
January 15, 2021
Cardioprotective potential of amygdalin against angiotensin II induced cardiac hypertrophy, oxidative stress and inflammatory responses through modulation of Nrf2 and NF-κB activation
Yen-Lun Kung, Cheng-You Lu, Khan Fareen Badrealam, et al.
Annals of Surgical Oncology
|
October 26, 2018
A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study
Xin Tang, Xiaojuan Zhou, Yanying Li, et al.
Translational Lung Cancer Research
|
November 14, 2025
Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory study
Yijia Du, Yanying Li, Min Yu, et al.
Journal of the American Chemical Society
|
July 7, 2026
Interfacial Nucleation Pathways Governing Polymorph Selection Revealed by Synchrotron-Based <i>In Situ</i> GIWAXS and Molecular Simulations
Yu Liu, Xu Zhang, Xingfan Zhang, et al.
British Journal of Cancer
|
February 14, 2018
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)
Baohui Han, Kai Li, Yizhuo Zhao, et al.
BMC Cancer
|
February 7, 2015
Concurrent paclitaxel-based chemo-radiotherapy for post-surgical microscopic residual tumor at the bronchial margin (R1 resection) in non-small-cell lung cancer
Meixiang Zhou, Tao Li, Yongmei Liu, et al.
JTO Clinical and Research Reports
|
November 17, 2025
AdvanTIG-204: A Phase 2, Randomized, Open-Label Study of Ociperlimab Plus Tislelizumab and Concurrent Chemoradiotherapy Versus Tislelizumab and Concurrent Chemotherapy Versus Concurrent Chemoradiotherapy in First-Line Limited-Stage SCLC
Youling Gong, Qingsong Pang, Rong Yu, et al.
Page
of 58